Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Mccarvel Thomas JDirector | Grant or award | A | — 1,232 sh | Nov 4, 2026 |
| 9 | Stiefel Justin BDirector, CEO & Treasurer | Option exercise | M | — 1,458 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Affleck-Graves John FDirector | Grant or award | A | $21K 243 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 9 | Siva Nilakanta AmareshChief Info & Tech Officer | Grant or award | A | — 59.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Sengupta RudraSVP Chief Tech and AI Officer | Tax withholding | F | $33K 201 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 9 | Vandemore John MEVP and CFO | Grant or award | A | — 264.8K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Flavin LisaSenior VP & CCO | Grant or award | A | — 4,428 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Hu Da-WaiEVP & General Counsel | Grant or award | A | — 28.9K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $490K 2,000 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $295K 1,200 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 9 | Nithrakashyap ArvindDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $486K 4,140 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 9 | Nithrakashyap ArvindDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $814K 7,000 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 9 | Brown Matthew CharlesDirector | Grant or award | A | — 2,683 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Nithrakashyap ArvindDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $587K 4,988 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 9 | Marinaro MichaelPresident | Grant or award | A | — 6,547 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Nithrakashyap ArvindDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $540K 4,561 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 9 | Berry Jason MEVP & Chief Operating Officer | Option exercise | M | — 3,910 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Singh SumitDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $69K 3,228 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Vandemore John MEVP and CFO | Grant or award | A | — 794.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Spector DavidDirector, Chairman & CEO | Other acquisition or disposition | J | — 25.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Tatusko Michael GSenior Vice President | Tax withholding | F | $23K 171 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 9 | Merriman Dwight ADirector | Open-market sale · 10b5-1 plan | SELL | $278K 800 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Printer HoshiDirector | Option exercise | M | — 8,541 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Walsh Kenneth MDirector | Grant or award | A | — 1,232 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Swartz AllisonEVP, GC | Grant or award | A | — 11.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | McLoughlin ChristopherChief Legal Officer | Grant or award | A | — 4,168 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Wassil JimEVP, Chief Scientific Ofc, COO | Open-market sale · 10b5-1 plan | SELL | $116K 1,907 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Sing George LDirector | Option exercise | M | — 7,830 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Berry Jason MEVP & Chief Operating Officer | Option exercise | M | — 663 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 9 | Warren JoshuaEVP, Chief Financial Officer | Grant or award | A | — 9,376 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Coloma Jason VDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $166K 5,345 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Davis Robert EmersonDirector | Grant or award | A | — 58.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Ticho BarryCHIEF MEDICAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $185K 6,995 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Palatnik Kevin S.Director | Option exercise | M | — 8,541 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Derhacobian NarbehDirector | Option exercise | M | — 8,541 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Vassil JonathanChief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $67K 1,951 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Allison Richard E JrDirector | Grant or award | A | — 300 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $406K 1,671 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Peabody MarkExecutive VP & Pres-Aerospace | Option exercise | M | $48K 1,831 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 9 | Boland Julie ADirector | Grant or award | A | — 92 sh | Nov 4, 2026 traded Nov 2, 2026 |